Chronic Kidney Disease

Caring for Individuals With Kidney Disease During the Pandemic

January 20th 2021, 9:00pm


Nephrologist Mary Dittrich, MD, the chief medical officer and executive vice president of U.S. Renal Care as well as cofounder and partner of Boise Kidney & Hypertension Institute, discusses how to keep patients safe while providing high-quality kidney care during the coronavirus disease 2019 pandemic.

Family History, Genetics May Help to Predict, Detect Early-Stage CKD

January 16th 2021, 4:00pm


A population-based study from the Netherlands showed that individuals with had at least 1 direct relative affected with chronic kidney disease (CKD), suggesting that biomarkers for CKD can aid in detecting the early stages of the disease.

Examining the Shift to Value-Based Kidney Care Delivery in 2021

January 12th 2021, 7:20pm


On this episode of Managed Care Cast, we speak with the new chief financial officer of Strive Health, a value-based kidney care company that works with payers and providers to create an integrated care delivery system for chronic kidney disease and end-stage renal disease (ESRD). We discuss the changes coming to nephrology practices, as well as new ways of looking at the whole patient to halt the slide to irreversible ESRD.

FDA Grants Priority Review to Dapagliflozin for CKD

January 8th 2021, 6:30pm


The FDA decision on dapaglifozin for CKD is expected in the second quarter of 2021.

Large Swedish Study Says Stopping RAS Inhibitors Leads to Worse CKD Outcomes

January 3rd 2021, 1:00pm


A new study from Sweden cautions against routine discontinuation of renin-angiotensin system (RAS) inhibitors in patients with chronic kidney disease (CKD).

Dr Guofen Yan Considers Strategies for Improving CKD Outcomes in Minority Populations

December 31st 2020, 12:15pm


Slowing progression of chronic kidney disease can help mitigate adverse outcomes in minority populations, said Guofen Yan, PhD, associate professor of biostatistics in the Department of Public Health Sciences at the University of Virginia School of Medicine.

Dr Kunihiro Matsushita Lays Out the Benefits of the CKD Patch Approach

December 31st 2020, 11:00am


This approach allows clinicians to keep using existing prediction models and incorporate chronic kidney disease (CKD) data seamlessly to calibrate patients' risks, said Kunihiro Matsushita, MD, an associate professor in the Department of Epidemiology and Division of Cardiology at Johns Hopkins University.

Top 5 Most-Read Chronic Kidney Disease Articles of 2020

December 28th 2020, 1:00pm


Two story lines predominated renal news in 2020: coronavirus disease 2019's effect on the kidneys and the overwhelming benefits of sodium-glucose cotransporter 2 inhibitors for those with chronic kidney disease and type 2 diabetes.

Contributor: How Payers Can Be Effective in New Value-Based Models for CKD

December 26th 2020, 10:15pm


The author discusses how value-based payment models in chronic kidney disease can improve total cost and quality of care for patienst with chronic kidney disease (CKD).

Virtual Platform Allows Transplant Evaluations, Wait-Listing to Continue Despite Pandemic

December 26th 2020, 4:40pm


A study evaluating whether a virtual platform can improve access to evaluations for kidney transplants found that surgical teams could continue to keep up with evaluations adding patients to wait lists during the pandemic.